Status:
COMPLETED
Feasibility Bowel Dysfunction Program After Low Anterior Resection
Lead Sponsor:
Fox Chase Cancer Center
Conditions:
Rectal Cancer
Low Anterior Resection
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study will facilitate a better understanding of the overall experience of our rectal cancer survivors after Low Anterior Resection for rectal cancer. Studies have demonstrated that the developmen...
Detailed Description
Subjects will be recruited from patients presenting to the surgical oncology clinic at Fox Chase Cancer Center. These patients will have already undergone Low Anterior Resection with a diverting stoma...
Eligibility Criteria
Inclusion
- Diagnosis of Stage II or III rectal cancer, a history of having an LAR with diverting stoma, and a plan to undergo stoma reversal within the next 6 months
Exclusion
- Patients enrolled who develop an anastomotic leak at the time of stoma reversal that would necessitate another temporary or permanent stoma, they will be considered unevaluable and will be excluded from the analysis
Key Trial Info
Start Date :
February 19 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2018
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04733794
Start Date
February 19 2016
End Date
December 18 2018
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111